⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEM News
Tempus AI, Inc. Class A Common Stock
Form 8-K
sec.gov
TEM
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed
prnewswire.com
AMD
HYFT
RXRX
ABSI
TEM
NVDA
Personalis Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Personalis, Inc. - PSNL
businesswire.com
TEM
PSNL
Form 8-K
sec.gov
TEM
PERSONALIS SHAREHOLDER ALERT: PSNL Shareholders Interested in Pursuing Potential Claims Should Contact Julie & Holleman Regarding Proposed Sale to Tempus
globenewswire.com
PSNL
TEM
Form 8-K
sec.gov
PSNL
TEM
Form 8-K
sec.gov
TEM
Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform
businesswire.com
TEM
PSNL
As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data
prnewswire.com
ABCL
HYFT
SDGR
RXRX
TEM
Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers
businesswire.com
TEM